Literature DB >> 20025058

Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation.

Sang Ryong Kim1, Eun Sook Chung, Eugene Bok, Hyung Hwan Baik, Young Cheul Chung, So Yoon Won, Eunhye Joe, Tae Hyong Kim, Soung Soo Kim, Min Young Jin, Sang Ho Choi, Byung Kwan Jin.   

Abstract

We have shown that prothrombin kringle-2 (pKr-2), a domain of human prothrombin distinct from thrombin could activate cultured rat brain microglia in vitro. However, little is known whether pKr-2-induced microglial activation could cause neurotoxicity on dopaminergic (DA) neurons in vivo. To address this question, pKr-2 was injected into the rat substantia nigra (SN). Tyrosine hydroxylase (TH) immunohistochemistry experiments demonstrate significant loss of DA neurons seven days after injection of pKr-2. In parallel, pKr-2-activated microglia were detected in the SN with OX-42 and OX-6 immunohistochemistry. Reverse transcription PCR and double-label immunohistochemistry revealed that activated microglia in vivo exhibit early and transient expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) and several proinflammatory cytokines. The pKr-2-induced loss of SN DA neurons was partially inhibited by the NOS inhibitor N(G)-nitro-L-arginine methyl ester hydrochloride, and the COX-2 inhibitor DuP-697. Extracellular signal-regulated kinase 1/2, c-Jun N-terminal kinase and p38 mitogen-activated protein kinase were activated in the SN as early as 1 hr after pKr-2 injection, and localized within microglia. Inhibition of these kinases led to attenuation of mRNA expression of iNOS, COX-2 and several proinflammatory cytokines, and rescue of DA neurons in the SN. Intriguingly, following treatment with pKr-2 in vitro, neurotoxicity was detected exclusively in co-cultures of mesencephalic neurons and microglia, but not microglia-free neuron-enriched mesencephalic cultures, indicating that microglia are required for pKr-2 neurotoxicity. Our results strongly suggest that microglia activated by endogenous compound(s), such as pKr-2, are implicated in the DA neuronal cell death in the SN. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20025058     DOI: 10.1002/jnr.22318

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  19 in total

1.  Translocator protein 18 kDa negatively regulates inflammation in microglia.

Authors:  Keun-Ryung Bae; Hyun-Jung Shim; Deebika Balu; Sang Ryong Kim; Seong-Woon Yu
Journal:  J Neuroimmune Pharmacol       Date:  2014-04-01       Impact factor: 4.147

2.  Prothrombin kringle-2, a mediator of microglial activation: new insight in Alzheimer's disease pathogenesis.

Authors:  Jae Man Lee; Sang Ryong Kim
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

3.  Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix.

Authors:  Chandra Shekhar Boosani; Yakkanti A Sudhakar
Journal:  Pharmaceuticals (Basel)       Date:  2011-12

4.  Thrombin a-chain: activation remnant or allosteric effector?

Authors:  Isis S R Carter; Amanda L Vanden Hoek; Edward L G Pryzdial; Ross T A Macgillivray
Journal:  Thrombosis       Date:  2010-12-09

5.  Inhibition of microglial activation and induction of neurotrophic factors by flavonoids: a potential therapeutic strategy against Parkinson's disease.

Authors:  Sang Ryong Kim
Journal:  Neural Regen Res       Date:  2015-03       Impact factor: 5.135

6.  Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.

Authors:  Lijuan Bai; Xique Zhang; Xiaohong Li; Na Liu; Fan Lou; Honglei Ma; Xiaoguang Luo; Yan Ren
Journal:  Mol Med Rep       Date:  2015-03-13       Impact factor: 2.952

Review 7.  p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease.

Authors:  Saurabh Kumar Jha; Niraj Kumar Jha; Rohan Kar; Rashmi K Ambasta; Pravir Kumar
Journal:  Int J Mol Cell Med       Date:  2015

8.  Induction of microglial toll-like receptor 4 by prothrombin kringle-2: a potential pathogenic mechanism in Parkinson's disease.

Authors:  Won-Ho Shin; Min-Tae Jeon; Eunju Leem; So-Yoon Won; Kyoung Hoon Jeong; Sang-Joon Park; Catriona McLean; Sung Joong Lee; Byung Kwan Jin; Un Ju Jung; Sang Ryoung Kim
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

Review 9.  Naringin: a protector of the nigrostriatal dopaminergic projection.

Authors:  Un Ju Jung; Eunju Leem; Sang Ryong Kim
Journal:  Exp Neurobiol       Date:  2014-06-13       Impact factor: 3.261

Review 10.  Prothrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic System.

Authors:  Eunju Leem; Kyoung Hoon Jeong; So-Yoon Won; Won-Ho Shin; Sang Ryong Kim
Journal:  Exp Neurobiol       Date:  2016-08-08       Impact factor: 3.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.